Alzheimer’s disease (AD) represents a pressing global health challenge, with an anticipated surge in diagnoses over the next two decades. This progressive neurodegenerative disorder unfolds gradually, with observable symptoms emerging after two decades of imperceptible brain changes. While traditional therapeutic approaches, such as medication and cognitive therapy, remain standard in AD management, their limitations prompt exploration into novel integrative therapeutic approaches. Recent advancements in AD research focus on entraining gamma waves through innovative methods, such as light flickering and electromagnetic fields (EMF) stimulation. Flickering light stimulation (FLS) at 40 Hz has demonstrated significant reductions in AD pathologies in both mice and humans, providing improved cognitive functioning. Additionally, recent experiments have demonstrated that APOE mutations in mouse models substantially reduce tau pathologies, with microglial modulation playing a crucial role. EMFs have also been demonstrated to modulate microglia. The exploration of EMFs as a therapeutic approach is gaining significance, as many recent studies have showcased their potential to influence microglial responses. Th article concludes by speculating on the future directions of AD research, emphasizing the importance of ongoing efforts in understanding the complexities of AD pathogenesis through a holistic approach and developing interventions that hold promise for improved patient outcomes.

It has been previously reported that time-varying EMFs and LEDs have the potential to modulate cellular activity and cell viability. It has also been shown that cellular activity and state can be inferred by measuring the biophoton emission derived from these same cells. To identify if the brief application (15 min) of an LED (635 nm at 3 klx) or EMF (1–3 uT) could influence cell growth and subsequent biophoton emission characteristics, B16-BL6 cells were grown to confluence and exposed to a time-varying, frequency-modulated EMF, LED, or both. Before and after EMF and LED exposure, photon emission measurements were taken for 1 min at a 50 Hz sampling rate. Following the exposure and photon emission measurements, cell viability was assessed via the use of a hemocytometer. The results demonstrated that after only 15 min of exposure to a time-varying EMF, there was a 41.6% reduction in viable cells when compared to sham controls [t(25) = 2.4, p = 0.02]. This effect approached significance in the LED alone condition [p = 0.07] but was completely absent in the condition wherein the LED and EMF were applied simultaneously [p < 0.8]. Additionally, following exposure to only the LED, there was a significant increase in biophoton emission SPD values at 13 Hz from whole cell cultures [t(60) = 2.3, p = 0.021]. This biophoton emission frequency was also strongly correlated with the number of nonviable cells [r = −0.514] in the dish. Taken together, these data point to biophotons emitted from cell cultures at 13 Hz as a potential indicator of the number of nonviable cells in vitro. The summation of data here corroborates previous work demonstrating the efficacy of specific time-varying EMFs as a novel therapeutic for the inhibition of cancer cell growth. It also furthers our assertion that biophoton emission can be used as a novel detection tool for cell activity.

Neural oscillations in the alpha and theta bands have been linked to environmental factors, including geomagnetic disturbances, yet the temporal dynamics of these interactions remain poorly understood. This study examined the relationship between geomagnetic activity, quantified by the Kp index, and brain activity in low alpha (7–10 Hz) and theta (4–7 Hz) bands using two complementary approaches. In Experiment 1, archival EEG data from 238 subjects collected over four years were analyzed for correlations between daily Kp values and band power across a ±90-day window. Significant positive correlations (p < 0.01) emerged in both bands, with a spatially coherent peak in caudal regions occurring 19 days prior to EEG measurement. In Experiment 2, an independent sample of 22 participants was exposed to a simulated geomagnetic storm, and EEG was recorded at baseline and 19 days post-exposure. Paired-samples t-tests revealed significant within-subject reductions in theta, low alpha, and high alpha power over frontal and parietal regions, consistent with a delayed neural response. Together, these findings provide converging correlational and experimental evidence for a lagged influence of geomagnetic activity on human brain oscillations. The 19-day delay observed in both datasets suggests that geomagnetic disturbances may exert residual effects on neural dynamics well beyond immediate exposure, warranting further investigation into underlying mechanisms and potential behavioral relevance.